3Szc E H M, Rosevzwcig B A, Birenbaum D L, et al. Excisional conization of the cervic-uteri: a five-part review [J]. J Gynecol Surg, 1989,55(5) : 235-238.
4Ferenczy A. Management of patients with high gradc squmous intracp thelial lesions [J]. Cancer, 1995,76( 10 suppl) : 1928-1931.
5Grenha A, Grainger CI, Dailey LA, et al. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro[J]. Eur J Pharm Sci,2007,31(2):73-84.
6Li DH, Liu LM, Tian KL, et al. Synthesis,biodegradability and cytotoxieity of water-soluble isobutylchitosan [J]. Carbohydrate Polymers, 2007,67 (1) : 40-45.
7Kim JH, Kim YS, Park K, et al. Antitumor efficacy of cisplatin- loaded glycol chitosan nanoparticles in tumorbearing mice[J]. J Control Release, 2008, 127 (1) : 41- 49.
8Min K H,Park K,Kim YS,et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy[J]. J Control Release, 2008, 127 (3) : 208-218.
9Kim TH, Jin H, Kim HW, et al. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells[J]. Mol Cancer Ther, 2006,5 (7):1723- 1732.
10Weecharangsan W, Opanasopit P, Ngawhirunpat T. Chitosan lactate as a nonviral gene delivery vector in COS-1 cells[J]. AAPS Pharm Sci Tech,2006,7(3) :66-71.
